key: cord-0065920-aybkqbwg
authors: Abbasi, Elahe; Rezayat, Shiva; Saneei, Parvane
title: Comment on "Meta-analysis of omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome"
date: 2021-07-21
journal: Nutrition
DOI: 10.1016/j.nut.2021.111421
sha: 063cb0d6aaff2bb26ee0e45e4872c78ed2fce061
doc_id: 65920
cord_uid: aybkqbwg

nan

have performed an interesting meta-analysis on 12 randomized control trials (RCTs) to evaluate the clinical benefits of omega-3 polyunsaturated fatty acids (PUFA) administration on gas exchange, and clinical outcomes in acute respiratory distress syndrome (ARDS) patients. They concluded that omega-3 PUFAs in enteral immunomodulatory diets of critically ill patients with ARDS might decrease the severity of disease by improving early and late ratios of partial pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FiO2), while marginally significant effects were found for the improved intensive care unit (ICU) length of stay (LOS) and duration of mechanical ventilation (MV). Although the results are of great importance, several points need to be considered when interpreting these findings.

First, both the title of article and the aim of the study have focused on evaluating the effects of omega-3 PUFAs in critically ill patients, while 8 of 12 included trials have administered an immune-enhancing diet with eicosapentaenoic acid (EPA), g-linolenic acid (GLA), and antioxidants to the intervention arm. So, these trials have assessed the advantages of an enteral immunomodulatory diet or a combination of EPA, GLA and antioxidants, not merely omega-3 supplementation. In addition, a comprehensive literature search is an important process in a systematic review and meta-analysis and can affect the findings. An eligible published trial (with a relatively large study sample, n=102 participants) (2) was missed by the search in this meta-analysis.

Second, careful data extraction and methodological considerations are the other key steps in a meta-analysis; however, some issues were not taken into account in these processes in this meta-analysis. In case of several outcomes of interest, moderate-to-high between-study heterogeneity was found; however, the authors did not provide information about covariates that could explain the observed heterogeneity. Subgroup analysis based on potential confounders including type of intervention (assigning an immunomodulatory diet versus fish oil), type of secondary outcome (28-d versus hospital mortality) and treatment duration should be performed to determine the sources of heterogeneity. Evaluating dose-response effects could also provide more explanations. Furthermore, an improvement in early and late PaO2-to-FiO2 ratio was reported in abstract and figures which meant an increment in PaO2 along with a decrease in FIO2 that resulted in better oxygenation or greater PaO2-to-FiO2 ratio; however, the authors have stated that "the pooled estimate suggests that omega-3

PUFAs reduce early PaO2-to-FiO2 ratio" and "late PaO2-to-FiO2 ratio had a tendency toward a reduction only in single center trials" in the results. In case of mortality outcome, the authors claimed that two trials that reported 60-d mortality were not included in the aggregation; but the forest plot of mortality showed that one of these trials (Rice et al. 2011) was considered in the estimation of overall effect. In addition, the authors have performed stratified analysis by study quality and revealed no significant difference in mortality between subgroups based on result section; but in the abstract, they reported a significant reduction in mortality (P = 0.04) in trials at higher risk of bias.

Another crucial part of an investigation is appropriate citations; but relevant references were not cited in several cases. For example, the Berlin 2014 criteria for ARDS definition was mentioned in the introduction, however, it is inappropriately referenced to the Berlin 2012 definition. In the discussion, the authors referred to the first meta-analysis in 2008 evaluating the impact of an immune-enhancing diet on mortality and oxygenation in mechanically ventilated patients with ARDS, but they inaccurately cited an original article that was included in their meta-analysis (Pontes-Arruda et al. 2006) . Also, the authors reported a negative odds ratio (and 95% confidence intervals) for overall infections (odds ratio: -2.14, 95% CI -3.23, -1.04), when they reported the tests of asymmetry for this estimate; while an odds ratio is a relative measure of effect, which cannot give a negative value (3) .

Finally, when the authors evaluated publication bias, test for asymmetry was significant for overall infections; however, the trim-and-fill method was not applied to identify the impact of unpublished studies on overall estimate.

In conclusion, identifying the effect of omega-3 PUFA in critically Ill patients with ARDS have a great value; however, comprehensive literature search, careful methodological, statistical methods and appropriate referencing should be adopted to avoid any invalid conclusions.

Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis

Treating effects of early venous injection of

Omega-3 fish oil fatty acids to sepsis-induced ARDS

Statistics notes. The odds ratio